β-Endorphin

Beta-Endorphin (β-Endorphin) — Endogenous Opioid

Evidence & Status

  • Preliminary / Experimental
  • Preliminary

At a Glance

An endogenous 31-amino-acid POMC-derived opioid peptide studied in physiology and signaling research. Endogenous biology is not evidence that administered beta-endorphin is an established therapy or nootropic.

Plain English

Beta-endorphin is a peptide the body makes as part of the POMC system. Researchers study its endogenous role in pain, stress, and reward-related physiology. That biology is different from giving beta-endorphin as a drug, for which established therapeutic efficacy, dosing, and safety are not represented here.

Overview

Human beta-endorphin is an endogenous 31-amino-acid POMC-derived opioid peptide involved in endogenous opioid signaling. Its biology can be discussed in relation to pain modulation, stress responses, and reward-related physiology, but endogenous associations do not establish efficacy of administered beta-endorphin. This record is not a routine nootropic or an established therapeutic peptide.

Research Summary

The evidence represented here concerns endogenous beta-endorphin physiology, including opioid signaling, pain modulation, stress responses, and reward-related physiology. These associations do not establish efficacy of administered beta-endorphin. Direct therapeutic safety of administered beta-endorphin is not established from the evidence represented in this record, and general opioid-drug risks must not be transferred by analogy.

Research Areas

  • Endogenous opioid physiology
  • Pain modulation
  • Stress responses
  • Reward-related physiology
  • POMC biology

Safety & Risks

Serious Risks

  • Direct therapeutic safety of administered beta-endorphin is not established from the evidence represented in this record.

Reported Side Effects

  • No established exogenous therapeutic safety profile is represented in this record.
United States
No established approved beta-endorphin therapeutic product/indication is represented by this record.
United Kingdom
No established approved beta-endorphin therapeutic product/indication is represented by this record.
Australia
No established approved beta-endorphin therapeutic product/indication is represented by this record.
Canada
No established approved beta-endorphin therapeutic product/indication is represented by this record.